Prevalence and covid 19 vaccination rate in a population of patients with schizophrenia and a substance use disorder
Introduction As of August 27th, 2021, the diagnosed cases of COVID 19 in Spain are 4 758 003 with a prevalence of 10.03%. 68.4% of the Spanish population is fully vaccinated Objectives Primary: To compare the prevalence of COVID infection in a cohort of patients with schizophrenia to patients with...
Main Authors: | S.L. Romero Guillena, I. De Burgos Berdud, R. Gálvez Medina, E. Serrano Rodriguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S092493382200685X/type/journal_article |
Similar Items
-
Comparison of prevalence, clinical evolution, and vaccination rate against covid 19 in a population of patients diagnosed with dual depression and non-dual depression
by: S.L. Romero Guillena, et al.
Published: (2022-06-01) -
The incidence of depressive disorders in patients with schizophrenia
by: M. A. Novitskiy, et al.
Published: (2021-10-01) -
The prevalence of self-harm behavior in schizophrenia spectrum disorders: a systematic review and meta-analysis
by: E. Lorentzen, et al.
Published: (2022-06-01) -
Attitudes towards Vaccines, Intent to Vaccinate and the Relationship with COVID-19 Vaccination Rates in Individuals with Schizophrenia
by: Stéphane Raffard, et al.
Published: (2022-07-01) -
Sex differences in the prevalence and clinical correlates of diabetes in Chinese patients with chronic schizophrenia
by: Huiming Yan, et al.
Published: (2023-03-01)